✦ LIBER ✦

Strontium ranelate—Data on vertebral and nonvertebral fracture efficacy and safety: Mechanism of action

✍ Scribed by David L. Kendler

Book ID: 107546959
Publisher: Current Science Inc.
Year: 2006
Tongue: English
Weight: 94 KB
Volume: 4
Category: Article
ISSN: 1544-1873
DOI: 10.1007/s11914-006-0013-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strontium ranelate: New data on fracture

Strontium ranelate: New data on fracture prevention and mechanisms of action

✍ Jean-Yves Reginster; Rita Deroisy; Audrey Neuprez; Mickaël Hiligsmann; Brigitte 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 227 KB

Effects of long-term strontium ranelate

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

✍ Jean-Yves Reginster; Dieter Felsenberg; Steven Boonen; Adolfo Diez-Perez; Rene R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Five years treatment with strontium rane

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age

✍ Ego Seeman; Steven Boonen; Frederik Borgström; Bruno Vellas; Jean-Pierre Aquino; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A meta-analysis of the effect of stronti

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®

✍ J. A. Kanis; H. Johansson; A. Oden; E. V. McCloskey 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 321 KB

Erratum to: A meta-analysis of the effec

Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®

✍ J. A. Kanis; H. Johansson; A. Oden; E. V. McCloskey 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 58 KB

An evaluation of the Fracture Risk Asses

An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®

✍ J.-M. Kaufman, S. Palacios, S. Silverman, S. Sutradhar… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 559 KB